After a jury awarded $6.5 million to a California man and his wife who alleged he developed bladder cancer after taking the diabetes drug Actos, attorney Sara Gourley filed a motion challenging the plaintiffs' expert — and succeeded in getting the entire verdict thrown out.
"We're taking those lessons and going on to the next case," said Gourley, a partner in Sidley Austin's Chicago office and lead counsel in the first Actos trial for defendants Takeda Pharmaceuticals North America Inc. and Eli Lilly and Co. The defendants face more than 3,000 cases filed after the U.S. Food and Drug Administration warned that taking Actos for more than a year could increase a patient's risk of getting bladder cancer.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
